Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Heatmap
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
GERN
#2376
Geron Corp
1.7
7
USD
+2.31%
Secteur:
Soins de Santé
Base:
USD
Devise de Profit:
USD
Range quotidien
Range Annuel
Changement quotidien
+2.31%
Changement Mensuel
+11.32%
Evolution sur 6 mois
+39.37%
Changement Annuel
+35.11%
Clôture Précédente
1.7
3
Open
1.7
7
Bid
Ask
Low
1.7
7
High
1.7
7
Volume
71
Marchés
Actions des Marchés US
Soins de Santé
GERN
Open full chart
Financials
Overview
Relevé
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
318.53 M
323.73 M
508.72 M
546.06 M
636.9 M
640.54 M
—
Valuation ratios
Enterprise value
526.25 M
414.18 M
1.2 B
1.14 B
2.3 B
888.95 M
3.8 B
Price to earnings ratio
—
—
-6.49
-6.69
-13.11
-10.15
-39.99
Price to sales ratio
—
—
1 533.36
5 152.66
-1 339.75
—
—
Price to cash flow ratio
—
—
-7.17
-7.28
-10.46
-7.93
-25.05
Price to book ratio
—
—
11.42
4.93
8.16
3.9
6.51
Enterprise value to EBITDA ratio
-6.55
-3.22
-8.42
-5.38
-8.2
-2.97
—
Profitability ratios
Return on assets %
-0.28
-0.51
-0.74
-0.47
-0.29
-0.15
-0.15
Return on equity %
-0.36
-0.92
-1.77
-0.74
-0.62
-0.37
-0.34
Return on invested capital %
-370.38
-500.89
-861.79
-727.02
-533.33
-95.12
—
Gross margin %
100
100
100
100
100
—
—
Operating margin %
-30.4 K
-8 183.7
-23.25 K
-81.83 K
10.18 K
—
—
EBITDA margin %
-29.94 K
-8 017.37
-23.19 K
-86.08 K
15.54 K
—
—
Net margin %
-29.89 K
-8 335.39
-23.81 K
-77.69 K
10.23 K
—
—
Liquidity ratios
Quick ratio
—
—
—
—
5.12
3.62
22.25
Current ratio
6.46
4.11
2.35
3.16
5.56
4.66
26.35
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0
0.01
0
0
-0
0
—
Solvency ratios
Debt to assets ratio
0.11
0.24
0.18
0.1
0.2
0.21
0.86
Debt to equity ratio
0.14
0.43
0.42
0.15
0.43
0.54
1.94
Long term debt to total assets ratio
0.09
0.22
0.16
0.09
0.2
0.21
0.85
Long term debt to total equity ratio
0.11
0.39
0.38
0.14
0.42
0.53
1.91
Per share metrics
Operating cash flow per share
—
—
-0.33
-0.29
-0.34
-0.17
-0.17
EBIT per share
—
—
-0.36
-0.34
-0.39
-0.38
—
EBITDA per share
—
—
-0.36
-0.36
-0.41
-0.39
—
Total debt per share
—
—
0.09
0.07
0.19
0.18
0.73
Cash per share
—
—
0.45
0.58
0.63
0.12
0.48
Net current asset value per share
—
—
0.47
0.6
0.76
0.78
3.07
Tangible book value per share
—
—
0.21
0.43
0.43
0.34
1.5
Working capital per share
—
—
0.27
0.41
0.62
0.61
2.58
Book value per share
—
—
0.21
0.43
0.43
0.34
1.5
Geron Corporation
Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase.
Nouvelles
Geron nomme Patricia S. Andrews et Constantine Chinoporos au conseil d’administration
Geron à la conférence santé de Barclays : croissance stratégique
Geron at Barclays Healthcare Conference: Strategic Growth and Future Plans
Geron Corporation (GERN) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Can Reblozyl Stabilize BMY's Top Line Amid Legacy Drugs Decline?
Geron chez TD Cowen : croissance stratégique et expansion
Geron at TD Cowen: Strategic Growth and Market Expansion
Geron: Why I'm Doubling Down On My 'Sell' Rating After Q4 Earnings (NASDAQ:GERN)
Geron Corporation (GERN) Q4 2025 Earnings Call Transcript
Geron (GERN) Reports Q4 Loss, Misses Revenue Estimates
Le BPA de Geron a manqué les attentes de 0,02$, le CA en dessous des prévisions
Geron earnings missed by $0.02, revenue fell short of estimates